Alternative NSN: 6505-01-252-0802 |
Item Name: Clorazepate Dipotassium Tablets Usp |
CAGE Code : 70048 , 56287 , 62051 , 60895 , 4V824 , 64682 , 0MLD2 , 2T119 |
NIIN: 012520802 |
NCB Code: USA (01) |
Manufacturers: abbott laboratories inc , actavis inc , danbury pharmacal inc , mylan pharmaceuticals inc , rugby group inc , schein henry inc , taro pharmaceuticals usa inc , warner lambert ltd |
Part No Part No
|
Manufacturer |
Item Name Item Name
|
QTY QTY
|
RFQ RFQ
|
---|---|---|---|---|
4389-53 | abbott laboratories inc | clorazepate dipotassium tablets usp | Avl | |
NDC00074-4389-53 | abbott laboratories inc | clorazepate dipotassium tablets usp | Avl | |
NDC00228-3067-50 | actavis inc | clorazepate dipotassium tablets usp | Avl | |
NDC00591-0363-05 | danbury pharmacal inc | clorazepate dipotassium tablets usp | Avl | |
NDC00378-0030-05 | mylan pharmaceuticals inc | clorazepate dipotassium tablets usp | Avl | |
NDC00536-4940-05 | rugby group inc | clorazepate dipotassium tablets usp | Avl | |
NDC00364-2201-05 | schein henry inc | clorazepate dipotassium tablets usp | Avl | |
NDC51672-4042-02 | taro pharmaceuticals usa inc | clorazepate dipotassium tablets usp | Avl | |
NDC00047-0451-30 | warner lambert ltd | clorazepate dipotassium tablets usp | Avl |
MRC | Criteria | Characteristic |
---|---|---|
AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
Before You Go, You Should Consider Looking at Our NSN Parts Catalog. and Remember, ASAP Sourcing Solutions Has Some of the Fastest and Most Competitive Quotes On the Market.
Request for Quote